Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/22/9/2021/19446128/mdp547.pdf
Reference24 articles.
1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group;Lancet,2005
2. Gene expression profiling predicts clinical outcome of breast cancer;van ‘t Veer;Nature,2002
3. A gene-expression signature as a predictor of survival in breast cancer;van de Vijver;N Engl J Med,2002
4. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer;Buyse;J Natl Cancer Inst,2006
5. Validation of 70-gene prognosis signature in node-negative breast cancer;Bueno-de-Mesquita;Breast Cancer Res Treat,2009
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost-utility analysis of genomic profiling in early breast cancer in Colombia;Cost Effectiveness and Resource Allocation;2023-07-10
2. Cost-utility analysis of genomic profiling in early breast cancer in Colombia;2022-11-10
3. Gene Expression Assay in the Management of Early Breast Cancer;Current Medicinal Chemistry;2020-06-04
4. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis;Health Technology Assessment;2019-06
5. Mammaprint™: a comprehensive review;Future Oncology;2019-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3